Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of.

Slides:



Advertisements
Similar presentations
EP Testing and Use of Devices in Heart Failure HFSA 2010 Recommendations.
Advertisements

Does Preoperative Hemoglobin Value Predict Postoperative Cardiovascular Complications after Total Joint Arthroplasty? Kishor Gandhi MD, MPH, Eugene Viscusi.
G.N. Dalekos3, M. Elisaf2, A.I. Hatzitolios1
Student’s Research Group at the Department of Internal Medicine, Hypertension and Angiology The Medical University in Warsaw PULMONARY EMBOLISM – TOUGH.
Etiology distribution of patients with atrial fibrilation by echocardiography: results from a prospective study in 3755 adults Enes Abdovic Cantonal Hospital.
Blood Pressure Reduction Among Acute Stroke Patients A Randomized Controlled Clinical Trial Jiang He, Yonghong Zhang, Tan Xu, Weijun Tong, Shaoyan Zhang,
Morbidity & Mortality: 2012 Chart Book on Cardiovascular, Lung, and
Preliminary results from the C-Pulse OPTIONS HF European Multicenter Post-Market Study Holger Hotz, CardioCentrum Berlin, Berlin, Germany; Antonia Schulz,
Evidence That D-dimer Levels Predict Subsequent Thromboembolic and Cardiovascular Events in Patients with Atrial Fibrillation during Oral Anticoagulant.
Heart Failure Whistle Stop Talks No 1 HFrEF and HFpEF Definitions for Diagnosis Susie Bowell BA Hons, RGN Heart Failure Specialist Nurse.
Cardiovascular Epidemiology: Definitions Historical Perspectives and Assessing Risk of CVD Recent trends and population differences in CHD and CHD risk.
Valvular heart surgery in Rajavithi hospital Dr.WITTAWAT PIBUL Rajavithi Hospital.
Ventricular Diastolic Filling and Function
Cardiac Arrhythmias in Coronary Heart Disease SIGN 94.
Jennifer Doria-del Castillo
Hypertension By Dr. Nagwa Eid Saad Prof. Of Internal Medicine & Family Medicine In Cairo University.
JONATHAN MANT, MD; ABDALLAH AL-MOHAMMAD, MD; SHARON SWAIN, BA, PHD; AND PHILIPPE LARAMEE,DC,MSC, FOR THE GUIDELINE DEVELOPMENT GROUP CHRIS FONTIMAYOR MS-III.
COURAGE: Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation Purpose To compare the efficacy of optimal medical therapy (OMT)
Emily O’Brien, Emil Fosbol, Andrew Peng, Karen Alexander, Matthew Roe, Eric Peterson The Obesity Paradox: The Importance for Long-term Outcomes in Non-ST-Elevation.
Heart Failure Ben Starnes MD FACC Interventional Cardiology
BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.
SIGN CHD In Scotland in the year ending 31 March 2006 over 10,300 patients died from CHD and 5,800 from cerebrovascular disease, with.
Dr. Mehdi Reza Emadzadeh Department of cardiology Mashhad University of Medical Science.
© Continuing Medical Implementation ® …...bridging the care gap Cardiovascular Aging.
Atrial Fibrillation Andreas Stein Robert Smith, M.D. August 11, 2003.
AN ASSESSMENT OF THE PRIMARY PREVENTION CONTROL PROGRAM OF PHC PREVENTIVE CARDIOLOGY CLINIC AMONG PATIENTS AT RISK FOR CVD: A Retrospective Cohort Study.
Current Management of Heart Failure GP clinical update 17 th June 2015 Dr Raj Bilku Consultant Cardiologist Clinical Lead Cardiology QEH.
Cardiovascular Disease in Women Module I: Epidemiology.
Dr. Atapour Nephrologist. Hypertension Blood pressure levels are a function of cardiac output multiplied by peripheral resistance (the resistance in.
Department faculty and hospital therapy of medical faculty and department internal diseases of medical prophylactic faculty. Cardiac arrhythmia Docent.
Working Group of Heart Failure and Cardiac Function How to evaluate and treat dyssynchrony ? P Lancellotti, LA Piérard, Liège, BE.
Specialized Atrial Fibrillation Clinic reduces cardiovascular morbidity and mortality in patients with atrial fibrillation Jeroen ML Hendriks, MSc Robert.
The Relationship Between Renal Function and Cardiac Structure, Function, and Prognosis Following Myocardial Infarction: The VALIANT Echo Study Anil Verma,
Presenter Disclosure Information John F. Beshai, MD RethinQ Trial Results Disclosures Information: The following relationships exist related to this presentation:
RELATIVE TOXICITY OF CITALOPRAM AND OTHER SSRIs IN OVERDOSE GK Isbister 1,2, IM Whyte 1,2, AH Dawson 1,2 1 Department of Clinical Toxicology, Newcastle.
Red Cell Distribution Width (RDW) as a Novel Prognostic Marker in Heart Failure: Data from the CHARM Program and the Duke Databank.
Cardiovascular disease in pregnancy Cardiovascular disease in pregnancy Dr.Z Allameh MD.
Relationship between total cholesterol and 90-day mortality after acute myocardial infarction in patients not on statins Rishi Parmar 2 nd year Medicine.
Clinical Symptoms of Atrial Fibrillation according to QTc Interval Duration Kulik V.L., Yabluchansky N.I. Medical Clinics Chair National University of.
Cerebro-Vascular Pathology of Elderly diabetics 72 case-studies S. Hannat - R. Chermat - R. Malek Internal Medical Service University Hospital Centre Setif.
How To Look To Patient Data DATA History Taking o Growth o Exercise Intolerance o Recurrent Chest Infection o Syncopal Attacks o Squatting.
Exercise Management Atrial Fibrillation Chapter 9.
Etiological Distribution of Chronic and Transient Atrial Fibrillation in Patients at Cantonal Hospital Zenica Enes Abdović 10 yrs Prospective Study, 29.
Preoperative Hemoglobin A1c and the Occurrence of Atrial Fibrillation Following On-pump Coronary Artery Bypass surgery in Type-2 Diabetic Patients Akbar.
Embargoed Until 3:45 p.m. ET, Sunday, Nov. 8, 2015
Perindopril Remodeling in Elderly with Acute Myocardial Infarction PREAMIPREAMI Presented at The European Society of Cardiology Hot Line Session, September.
Rapid assessment of chest pain Dr Phil Avery Prince Philip Hospital Hywel Dda Health Board PCCS 18 th May 2011.
Kelsey Vonderheide, PA1.  Heart Failure—a large number of conditions affecting the structure and function of the heart that make it difficult for the.
Prevalence of preserved left ventricular function among patients admitted for pulmonary oedema F.HAZIZA, N.COHEN, J.F.LANDAU, A.C.GUIOMARD. Service de.
Left Ventricular Filling Pressure by Doppler Echocardiography in Patients With End-Stage Renal Disease Angela Y-M Wang, Mei Wang, Christopher W-K Lam,
CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.
Flow-Gradient Patterns in Severe Aortic Stenosis With Preserved Ejection Fraction Clinical Characteristics and Predictors of Survival Mackram F. Eleid,
Primary Mitral Regurgitation Degenerative Mitral Valve Disease
Alcohol, Other Drugs, and Health: Current Evidence July–August 2017
Angiotensin converting enzyme inhibitors / angiotensin receptor blockers and contrast induced nephropathy in patients receiving cardiac catheterization:
Heart & Thalassemia . R.Miri,MD, Interventional Cardiologist.
David M Kaye MD, PhD on behalf of the REDUCE LAP HF Investigators
P-18 HEART, VESSELS & DIABETES – THE EUROPEAN CONFERENCE, ATHENS, NOVEMBER, stress and inflammation as DETERMINATIVE FACTORS IN the PATIENTS.
Hypertension November 2016
Ivabradine – A new option for Heart Failure Patients
Copyright © 2007 American Medical Association. All rights reserved.
 Gender based differences in the presentation, treatment and outcome of Acute Coronary Syndrome patients : insights from the Himachal Pradesh ACS-registry.
Influence of Afterload on Global and Basal Longitudinal Strain: Comparison of Blood Pressure and Wall Stress Upasana Jarori, M. Waqas Choudhry, Shujaur.
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
PS Sever, PM Rothwell, SC Howard, JE Dobson, B Dahlöf,
ATHENA Trial Presented at Heart Rhythm 2008 in San Francisco, USA
Systolic Blood Pressure Intervention Trial (SPRINT)
Figure 1 Diagram showing analysis flow of patient selection and treatment allocation of ONTARGET/TRANSCEND. Figure 1 Diagram showing analysis flow of patient.
THE ELDERLY POPULATION
Hypertension November 2016
Presentation transcript:

Clinical Symptoms of Atrial Fibrillation in Different Ranges of QRS Duration Burda I.Yu., Yabluchansky N.I. Medical Clinics Chair National University of Karazin (Kharkov, Ukraine)

Reasons to Investigate Atrial fibrillation (AF) is the most frequent arrhythmia and generates 1/3 of all hospitalizations by arrhythmic cause. The incidence of AF increases with age and varies between less than 1% in people older than 60 years and almost 10% in all people older than 80 years. AF is associated to an increase in risk of stroke, heart failure (HF), and total mortality. Both QRS shortening and prolongation cause myocardial electric instability, intra- and interventricular asynchrony, intracardiac hemodynamic disorders, a decrease in cardiac ejection effectiveness, being as well, an independent predictor of mortality. Up to this date, there are no studies conducted to prove the relationship between the clinical symptoms of AF and QRS duration.

Objective of the Investigation To study the relationship between QRS duration and the clinical symptoms of AF, to improve the quality of the diagnosis and the management of this arrhythmia.

Investigated Population Patients selected for the study 98 patients (67 male and 31 female), ages between 45 and 87 years old with AF duration 6±5 years Form of AF –chronic – 65 –persistent – 27 –paroxysmal – 6 High blood pressure – 89 patients Coronary heart disease – 63 patients Combination of hypertension and CHD – 32 patients

Investigated Population Classification of the characteristics of patients Sex - male - male - female - female Age: – adults (45-60 years old men, years old women) - older adults (61-74 years old men, years old women) - older adults (61-74 years old men, years old women) - elderly (75-87 years old men and women) - elderly (75-87 years old men and women) Characteristics of AF Time of evolution (up to 10 years or more than 10 years) –form (chronic, persistent, paroxysmal) –classification by HR (bpm) – bradycardia (less than 60), normal (60-90) and tachycardia (more than 90) Degree of HF (FC І-ІІІ) LV ejection fraction (EF) (20-43%, 44-66% and 67-88%) Stable chronic angina (FC І-ІІІ) Systolic and diastolic pressure: normal BP – below 140/90 mm.Hg. - mild HBP (systolic mm.Hg., diastolic mm.Hg.) - mild HBP (systolic mm.Hg., diastolic mm.Hg.) - moderate HBP (systolic mm.Hg., diastolic mm.Hg.) - moderate HBP (systolic mm.Hg., diastolic mm.Hg.) - severe HBP (systolic more than 180 mm.Hg., diastolic more than 110 mm.Hg.) - severe HBP (systolic more than 180 mm.Hg., diastolic more than 110 mm.Hg.) History of AMI History of stroke

Investigated Population Inclusion and Exclusion Criteria Inclusion criteria AFHBP Stable chronic angina, FC I-III Endocarditis, myocarditis, pericarditis Valve diseases Exstrasystole Conduction disorders HF (FC I-III) Exclusion criteria Stable chronic angina, FC IV Acute coronary syndrome HF FC IV

Equipment Used and Parameters Evaluated Computer electrocardiograph “Cardiolab+” Parameters evaluated: HR (bpm) HR (bpm) QRS duration (ms) QRS duration (ms) Echocardiograph “SIM 5000 plus” Parameters evaluated: LV ejection fraction (%) LV ejection fraction (%) Blood pressure cuff Parameters evaluated: Systolic blood pressure in mm.Hg Systolic blood pressure in mm.Hg Diastolic blood pressure in mm.Hg Diastolic blood pressure in mm.Hg

Measurement of QRS Duration QRS duration was measured in 3 consecutive complexes in leads II, V1, V5, V6 Among the measured complexes, the one with the longest duration was chosen

Classification of QRS according to Duration Classification of QRS according to duration: - narrow (less than 60 ms) - narrow (less than 60 ms) - normal (from 60 to 100 ms) - normal (from 60 to 100 ms) - prolonged (longer than 100 ms) - prolonged (longer than 100 ms)

Statistical Analysis Data base in Microsoft Excel Statistical analysis with parametric methods Construction of graphs on the duration of QRS in different ranges

Distribution of QRS Duration in all the Patients The distribution is asymmetrical, shifted to lower values. The QRS duration of most patients is within the range of 91 to 100 ms. No narrow complexes are observed (of less than 60 ms). Most patients had prolonged complexes.

Relationship between Gender and QRS Duration The ratio between women (dark violet bars) and men (light violet bars) was 2:1. The distribution of QRS duration in all the patients was similar to the one in each group separately.

Relationship between Age and QRS Duration The greatest range of QRS duration dispersion was observed in the subset of elderly patients, the smallest in the adults subset. In the subsets of adults and elderly patients, most individuals are men, in the subset of older adults the ratio of men to women is 1:1.

Relationship between AF Forms and QRS Duration The ratio between the patients with paroxysmal or persistent AF (light violet bars) and chronic AF (dark violet bars) was 1:2. An asymmetrical distribution is observed, shifted to the lower values. For the chronic AF subset, the distribution is similar to the normal one. The patients with persistent or paroxysmal AF are in the range within 91 to 100 ms.

Relationship between HR and QRS Duration The ratio between the subsets with bradycardic (white bars), normal (dark violet bars) and tachycardic (light violet bars) AF was 1:6:5 respectively. The greatest range of QRS duration was for “normal” AF (between 70 and 190 ms), the smallest for bradycardic AF (between 100 and 170 ms). For normal and tachycardic AF, an asymmetrical distribution is observed, shifted to the lower values; for bradycardia, the distribution is more even throughout the range.

Relationship between the Time of Evolution of AF and QRS Duration The ratio between the patients with AF of less than 10 years (light violet bars) and of more than 10 years (dark violet bars) of evolution was 4:1. In the subset of less than 10 years of evolution, the range of QRS dispersion was broader, in the subset of more than 10 years, narrower. The distribution in both subsets was asymmetrical, shifted to the lower values.

Relationship between the Functional Class of HR and QRS Duration The ratio between the patients with FC I (light violet bars), FC II (dark violet bars) and FC III (white bars) HR was 1:3:2, respectively. While the FC advances, QRS duration increases (the maximal QRS duration increases from 140 to 190 ms). The distributions in all subsets are asymmetrical, shifted to the lower values.

Relationship between the LV Ejection Fraction and QRS Duration The ratio between the patients with ejection fraction of 20-43%, 44-66%, and 67-88% was 1:4:2, respectively. As QRS duration increases, the ejection fraction decreases. The maximal QRS duration was observed in the subset with the ejection fraction of 44-66%. The distributions in all subsets are asymmetrical with a shift to lower values.

Relationship between Functional Class of Stable Chronic Angina and QRS Duration The ratio between patients with FC I, FC II, and FC III was 1:3:4, respectively. While the FC increases, QRS duration increases (its maximal values increase from 120 to 180 ms). The distributions in all subsets are asymmetrical with a shift to lower values.

Relationship between Blood Pressure and QRS Duration The ratio between patients without HBP (light violet bars) and with a mild (dark violet bars), moderate (white bars), and severe increase (light blue bars) of systolic BP was 5:3:2:1, respectively. The ratio between patients without HBP and with mild, moderate, and severe increase of diastolic BP was 5:2:2:1. The maximal duration of QRS is observed in patients with moderate and severe HBP, according to their systolic BP, and moderate HBP, according to their diastolic BP. The distributions of systolic and diastolic BP are asymmetrical with a shift to lower values.

Relationship between History of AMI and QRS Duration The ratio between the patients with history of AMI (light violet bars) and without it (dark violet bars) was 1:8. The distributions in all the subsets are asymmetrical with a shift to lower values.

Relationship between History of Stroke and QRS Duration The relationship between the patients with history of stroke (light violet bars) and without it (dark violet bars) was 1:8. The distributions in all subsets are asymmetrical with a shift to lower values.

Conclusions In the patients studied, the dispersion of the QRS duration range was between 65 and 190 ms. No narrow complexes were seen, while in turn, broad complexes were found in half of the patients. The distributions of QRS duration were asymmetrical with a shift to lower values The distributions of QRS duration were asymmetrical with a shift to lower values. The greatest variability of QRS duration was observed in the following subsets: men, elderly patients, persistent and paroxysmal AF, “normal” AF, AF with no more than 10 years of evolution, FC III of heart failure, LV ejection fraction of 44-66%, FC III of stable chronic angina, moderate HBP, no history of AMI or stroke The greatest variability of QRS duration was observed in the following subsets: men, elderly patients, persistent and paroxysmal AF, “normal” AF, AF with no more than 10 years of evolution, FC III of heart failure, LV ejection fraction of 44-66%, FC III of stable chronic angina, moderate HBP, no history of AMI or stroke. The greatest variability of QRS duration was observed in the following subsets: women, older adults, chronic AF, bradycardic AF, AF of more than 10 years of evolution, FC I of heart failure, LV ejection fraction of 67-88%, FC I of stable chronic angina, mild HBP with history of AMI without stroke. While QRS duration increases, the FC of heart failure and the severity of HBP increase, and the LV ejection fraction decreases.. It is important to consider the QRS duration in AF diagnosis. QRS duration changes may reflect the effectiveness of therapeutic steps.